Population structure of gut Escherichia coli and its role in development of extra-intestinal infections

被引:0
|
作者
Katouli, M. [1 ]
Vollmerhausen, T. L. [1 ]
机构
[1] Univ Sunshine Coast, Fac Sci Hlth & Educ, Maroochydore, Qld 4556, Australia
关键词
E.coli; Urinary tract infection; Gut; Virulence factors;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Extra-intestinal pathogenic Escherichia coli (ExPEC) strains are divided into uropathogenic E. coli (UPEC), strains causing neonatal meningitis and septicaemic E. coli. The most common pathotype of ExPEC is found among patients with urinary tract infection (UTI), defined as UPEC. These bacteria are responsible for >90% of cases of UTI and are often found amongst the faecal flora of the same host. E. coli strains are classified into four phylogenetic groups, A, B1, B2, and D. Groups A and B1 are commensal strains and carry few virulence-associated genes (VGs) while pathogenic group B2 and D usually possess VGs which enhance colonic persistence and adhesion in the urinary tract (UT). The gastrointestinal (GI) tract is widely accepted as a reservoir for UPEC and is believed that healthy humans have a reservoir of UPEC strains, belonging to phylogenetic group B2, and to a lesser extent, group D. These strains have superior ability to survive and persist in the gut of humans and can spread to cause extra-intestinal infections. ExPEC trains possess a range of VGs which are involved in their pathogenesis. These include adhesins, toxins, iron-acquisition systems (e.g. siderophores), and capsules. Evolutionary influences on the acquisition and main role of VGs amongst E. coli are widely debated, with some research holding that the prevalence of strains with VGs increases the likelihood of infections, whereas others believe that VGs provide a selective advantage for infection of extra-intestinal sites. This review is intended to present our existing knowledge and gaps in this area.
引用
收藏
页码:59 / 72
页数:14
相关论文
共 50 条
  • [2] HEMOLYSIN CONTRIBUTES TO VIRULENCE OF EXTRA-INTESTINAL ESCHERICHIA-COLI INFECTIONS
    WELCH, RA
    DELLINGER, EP
    MINSHEW, B
    FALKOW, S
    NATURE, 1981, 294 (5842) : 665 - 667
  • [3] The population structure of clinical extra-intestinal Escherichia coli in a teaching hospital from Nigeria
    Seni, Jeremiah
    Peirano, Giselle
    Okon, Kenneth Okwong
    Jibrin, Yusuf Bara
    Mohammed, Alkali
    Mshana, Stephen E.
    DeVinney, Rebekah
    Pitout, Johann D. D.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 92 (01) : 46 - 49
  • [4] Different roles of host and bacterial factors in Escherichia coli extra-intestinal infections
    Wang, M. -C
    Tseng, C. -C.
    Wu, A. -B.
    Huang, J. -J.
    Sheu, B. -S.
    Wu, J. -J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (04) : 372 - 379
  • [5] THE LARGE-INTESTINE AS A RESERVOIR FOR ESCHERICHIA-COLI CAUSING EXTRA-INTESTINAL INFECTIONS
    SVANBORGEDEN, C
    HULL, S
    LEFFLER, H
    NORGREN, S
    PLOS, K
    WOLD, A
    REGULATORY AND PROTECTIVE ROLE OF THE NORMAL MICROFLORA, 1989, 52 : 47 - 58
  • [6] Extra-intestinal pathogenic Escherichia coli - threat connected with food-borne infections
    Wasinski, Bernard
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2019, 26 (04) : 532 - 537
  • [7] FIMBRIAL SEROTYPES OF ESCHERICHIA-COLI STRAINS ISOLATED FROM EXTRA-INTESTINAL INFECTIONS
    DEREE, JM
    VANDENBOSCH, JF
    JOURNAL OF MEDICAL MICROBIOLOGY, 1989, 29 (02) : 95 - 99
  • [8] DIVERSITY OF ESCHERICHIA-COLI ISOLATES IN EXTRA-INTESTINAL INFECTIONS AS DETERMINED BY ENZYME PATTERNS
    GOULLET, P
    PICARD, B
    JOURNAL OF INFECTION, 1985, 10 (03) : 283 - 284
  • [9] Altered membrane permeability in multidrug resistant Escherichia coli isolated from extra-intestinal infections
    Arora, Bindu
    Jagdale, Trupti
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2009, 8 (21): : 5995 - 5999
  • [10] Genomic analysis of extra-intestinal pathogenic Escherichia coli urosepsis
    McNally, A.
    Alhashash, F.
    Collins, M.
    Alqasim, A.
    Paszckiewicz, K.
    Weston, V.
    Diggle, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (08) : E328 - E334